pulmonary hypertension

January 11, 2018January 11, 2018

Bellerophon Enrolls First Patient in Study of INOpulse to Treat PH Linked to Interstitial Lung Disease

Idiopathic Pulmonary Fibrosis, News, Pulmonary Hypertension

A Phase 2b clinical study evaluating INOpulse as a treatment for pulmonary hypertension (PH) associated with interstitial lung disease (PH-ILD) enrolled the first patient, Bellerophon Therapeutics has announced. Patients with ... Read more

August 7, 2017August 7, 2017

FDA OKs Trial Design of INOpulse Device as Treatment for Pulmonary Hypertension Linked to Lung Disease

News

The U.S. Food and Drug Administration has signed off on the design of a Phase 2b trial of INOpulse, a device that delivers nitric oxide, as a treatment for patients with pulmonary ... Read more

July 18, 2017July 18, 2017

Mount Sinai, Theragene Collaborate to Develop New Gene Therapy for Pulmonary Hypertension

News, Pulmonary Hypertension

Researchers from New York’s Mount Sinai have partnered with Theragene Pharmaceuticals to further develop a new airway-delivered gene therapy for pulmonary hypertension (PH). After showing promising results in animal studies, this new therapy will advance to clinical trials, ... Read more

May 24, 2017June 19, 2017

INOpulse Nitric Oxide System Seen to Treat PH Patients with IPF and COPD Symptoms

COPD, Idiopathic Pulmonary Fibrosis, News, Pulmonary Hypertension

The INOpulse nitric oxide delivery system met its primary Phase 2 clinical trial goal of increasing the blood-vessel volume of pulmonary hypertension patients with idiopathic pulmonary fibrosis (PH-IPF), according to its maker, Bellerophon Therapeutics. ... Read more

May 2, 2017May 2, 2017

Bellerophon’s INOpulse Shows Promising Results in Patients with PH-IPF Lung Disease

Idiopathic Pulmonary Fibrosis, News, Pulmonary Hypertension

Inhaled nitric oxide (iNO) treatment with the investigational medical device INOpulse system in patients with pulmonary hypertension associated with idiopathic pulmonary fibrosis (PH-IPF) has shown promising results in a Phase 2 clinical ... Read more

August 15, 2016

Gene Based Diagnostic Tool for Rare Forms of Pulmonary Hypertension Developed by Researchers

News

A team of pulmonology and genetics specialists at the Intermountain Medical Center and ARUP Laboratories in Salt Lake City, Utah, jointly developed a diagnostic genomic testing method for rare forms of ... Read more

July 19, 2016July 19, 2016

Echocardiography Detects Lung Diseases of Premature Infants at Early Stages in Newborn Mice

News, Pulmonary Hypertension

Two common lung diseases in premature infants, bronchopulmonary dysplasia (BPD) and pulmonary hypertension (PH), might be detected by echocardiography at an earlier point than previously thought, reported researchers at Baylor College of ... Read more

July 11, 2016July 11, 2016

Key Protein Could Prevent Abnormal Arterial Changes in Pulmonary Hypertension

News, Pulmonary Hypertension

Researchers at the Medical College of Georgia at Augusta University found a specific protein that seems to cause abnormal blood vessel growth in pulmonary arterial hypertension (PAH). The protein, called galectin-3, or ... Read more

June 29, 2016June 29, 2016

PH Associated Idiopathic Interstitial Pneumonias: EMA Says ‘No’ to Adempas (Riociguat)

News, Pneumonia, Pulmonary Hypertension

The European Medicines Agency (EMA) has recommended against Adempas (riociguat) for patients with symptomatic pulmonary hypertension associated with idiopathic interstitial pneumonia (PH-IIP), according to a recent press release. EMA’s recommendation follows Bayer Pharmaceuticals‘ announcement in May for ... Read more

June 23, 2016June 23, 2016

SteadyMed and PHA Aim to Inspire Pulmonary Hypertension Patients with PHenomenal Campaign

News, Pulmonary Hypertension

SteadyMed and the Pulmonary Hypertension Association (PHA) recently launched the PHenomenal campaign, an initiative to offer people with pulmonary hypertension (PH) and their families a platform to share photos and videos of ... Read more